PEDIATRICS Vol. 108 No. 2 August 2001, pp. 421-425

Creatine Use Among Young Athletes

Received Apr 13, 2000; accepted Mar 22, 2001.

Jordan D. Metzl^*, Eric Small, Steven R. Levine^§, and Jeffrey C. Gershel

From the ^* Sports Medicine Service, Hospital for Special Surgery, Department of Pediatrics, Cornell Medical College, New York, New York;  Department of Pediatrics, Mount Sinai Medical Center, New York, New York; ^§ Department of Pediatrics, Northern Westchester Hospital Center, Mt Kisco, New York;  Department of Pediatrics, Jacobi Medical Center, Bronx, New York.

Objective.  Creatine is a nutritional supplement that is purported to be a safe ergogenic aid in adults. Although as many as 28% of collegiate athletes admit taking creatine, there is little information about creatine use or potential health risk in children and adolescents. Although the use of creatine is not recommended in people less than 18 years of age, numerous anecdotal reports indicate widespread use in young athletes. The purpose of this study was to determine the frequency, risk factors, and demographics of creatine use among middle and high school student athletes.

Methods.  Before their annual sports preparticipation physical examinations, middle and high school athletes aged 10 to 18 in Westchester County, a suburb north of New York City, were surveyed in a confidential manner. Information was collected regarding school grade, gender, specific sport participation, and creatine use.

Results.  Overall, 62 of 1103 participants (5.6%) admitted taking creatine. Creatine use was reported in every grade, from 6 to 12. Forty-four percent of grade 12 athletes surveyed reported using creatine. Creatine use was significantly more common (P < .001) among boys (53/604, 8.8%) than girls (9/492, 1.8%). Although creatine was taken by participants in every sport, use was significantly more common among football players, wrestlers, hockey players, gymnasts, and lacrosse players (P < .001 for all). The most common reasons cited for taking creatine were enhanced performance (74.2% of users) and improved appearance (61.3%), and the most common reason cited for not taking creatine was safety (45.7% of nonusers).

Conclusions.  Despite current recommendations against use in adolescents less than 18 years old, creatine is being used by middle and high school athletes at all grade levels. The prevalence in grades 11 and 12 approaches levels reported among collegiate athletes. Until the safety of creatine can be established in adolescents, the use of this product should be discouraged.  Key words:  creatine, nutritional supplements, ergogenic aids, adolescent sports medicine, preparticipation examination.

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. Calfee and P. Fadale Popular Ergogenic Drugs and Supplements in Young Athletes Pediatrics, March 1, 2006; 117(3): e577 - e589. [Abstract] [Full Text] [PDF]

				C. Rosenfield The Use of Ergogenic Agents in High School Athletes The Journal of School Nursing, December 1, 2005; 21(6): 333 - 339. [Abstract] [Full Text] [PDF]

				R. Dhar, C. W. Stout, M. S. Link, M. K. Homoud, J. Weinstock, and N. A. M. Estes III Cardiovascular Toxicities of Performance-Enhancing Substances in Sports Mayo Clin. Proc., October 1, 2005; 80(10): 1307 - 1315. [Abstract] [PDF]

				A. E. Field, S. B. Austin, C. A. Camargo Jr, C. B. Taylor, R. H. Striegel-Moore, K. J. Loud, and G. A. Colditz Exposure to the Mass Media, Body Shape Concerns, and Use of Supplements to Improve Weight and Shape Among Male and Female Adolescents Pediatrics, August 1, 2005; 116(2): e214 - e220. [Abstract] [Full Text] [PDF]

				K. A Pline and C. L Smith The Effect of Creatine Intake on Renal Function Ann. Pharmacother., June 1, 2005; 39(6): 1093 - 1096. [Abstract] [Full Text] [PDF]

				E. G. Boyce Use and Effectiveness of Performance-Enhancing Substances Journal of Pharmacy Practice, February 1, 2003; 16(1): 22 - 36. [Abstract] [PDF]

				P. A. Chyka Health Risks of Selected Performance-Enhancing Drugs Journal of Pharmacy Practice, February 1, 2003; 16(1): 37 - 44. [Abstract] [PDF]

eLetters: